Market Research Logo

Pharmaceuticals in Brazil

Pharmaceuticals in Brazil

Summary

Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Brazil pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Brazilian pharmaceuticals market had total revenues of $26.1bn in 2017, representing a compound annual rate of change (CARC) of -0.8% between 2013 and 2017.
  • Government investment in the country’s free National Healthcare System has improved the access to pharmaceuticals in recent years which have expanded beyond the São Paulo-Rio de Janeiro axis.
  • Brazil has been experiencing an epidemiological transition from communicable diseases to chronic degenerative diseases, which has increased the demand for drugs treating these diseases.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Brazil
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the Brazil pharmaceuticals market by value in 2017?
  • What will be the size of the Brazil pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Brazil's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aché Laboratórios Farmacêuticos S.A.
EMS Sigma Pharma
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Brazil pharmaceuticals market value: $ billion, 2013-17
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Brazil pharmaceuticals market share: % share, by value, 2017
Table 4: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Aché Laboratórios Farmacêuticos S.A.: key facts
Table 6: EMS Sigma Pharma: key facts
Table 7: Sanofi SA: key facts
Table 8: Sanofi SA: key financials ($)
Table 9: Sanofi SA: key financials (€)
Table 10: Sanofi SA: key financial ratios
Table 11: Brazil size of population (million), 2013-17
Table 12: Brazil gdp (constant 2005 prices, $ billion), 2013-17
Table 13: Brazil gdp (current prices, $ billion), 2013-17
Table 14: Brazil inflation, 2013-17
Table 15: Brazil consumer price index (absolute), 2013-17
Table 16: Brazil exchange rate, 2013-17
List of Figures
Figure 1: Brazil pharmaceuticals market value: $ billion, 2013-17
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Brazil pharmaceuticals market share: % share, by value, 2017
Figure 4: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in Brazil, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in Brazil, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in Brazil, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2017
Figure 11: Sanofi SA: revenues & profitability
Figure 12: Sanofi SA: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report